Results 221 to 230 of about 5,853,531 (371)

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee   +9 more
wiley   +1 more source

Machine learning for identifying liver and pancreas cancers through comprehensive serum glycopeptide spectra analysis: a case‐control study

open access: yesMolecular Oncology, EarlyView.
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima   +6 more
wiley   +1 more source

Conflict of Interest in Research

open access: yesJournal of Medical Evidence
Harish Gupta
doaj   +1 more source

Conflict of Interest Disclosure in American Arthroplasty Surgical Literature. [PDF]

open access: yesArthroplast Today
Tisherman RT   +7 more
europepmc   +1 more source

Medical Journals, Publishers, and Conflict of Interest.

open access: yesJournal of the American Medical Association (JAMA), 2017
Thomas J. Easley
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy